A modeling study predicts a substantial rise in MASLD prevalence and associated liver-related complications in the United ...
A new study published in the journal of Diabetes Research and Clinical Practice showed that metabolic dysfunction may be ...
The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...
In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.
Young adulthood obesity is associated with greater odds for MASLD, at-risk MASH, and increased liver stiffness measurement.
The following is a summary of "Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese ...
Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Dr. Sobia Laique, chair of the MASLD Task Force at Cleveland Clinic, introduces spacial genomics, which provides a high-resolution view of cellular heterogeneity and spacial organization ...
News Medical on MSN14d
Could a common sugar in processed foods be fueling childhood liver disease?Researchers found that high fructose intake, especially from processed foods, is linked to metabolic dysfunction-associated ...
Discover how semaglutide aids weight loss in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback